Fluor Corporation (NYSE: FLR) — A Charge-Prone Contractor Repriced as a Nuclear-and-Data-Center Pick-and-Shovel

Independent equity research note. Report date: 2026-07-24. General information only — not investment advice.

The analytical body of this article (Sections 1–15) is deliberately recommendation-free and price-target-free, and discusses valuation only as embedded expectations and scenarios. The single, clearly-labeled exception is the Author’s Take block immediately below — a subjective opinion, fenced off from the analysis.

⚡ Author’s Take

This block is the author’s own independent, subjective opinion. It is not investment advice and is general information only. Everything from the Executive Summary onward (Sections 1–15) carries no position and no price target.

Verdict: HOLD / AVOID-here. Not a short. Accumulate only on a pullback into the high-$30s–low-$40s. At $53.26 (23-Jul-2026), Fluor trades at the richest valuation-on-sales in its entire public history (P/S 0.62x = 99.7th percentile of its own 10-year range) and ~2.5x book, while the underlying business is what it has always been: a ~3.3–3.5% through-cycle EBIT-margin, pass-through-heavy, charge-prone engineering & construction contractor whose lifetime shareholder return is roughly zero and whose maximum drawdown is −96%. The market is repricing a survivor as a compounder.

There is a genuine bull case, and it is not stupid: the balance sheet is now clean (net cash, ~$2.4B harvested from a decade-old NuScale venture stake — a real capital-allocation coup), the pivot to reimbursable/cost-plus work (81% of backlog, 87% of new awards) has structurally cut the left-tail that nearly killed the company in 2019–20, and Fluor is levered to demand vectors investors love — nuclear/SMR, LNG, data-center power, copper, and US onshoring. But three things keep me on the sidelines. First, the P&L has never validated the margin-step-up thesis: a project charge lands almost every quarter (Santos $643M in FY25, plus infrastructure $108M, LOGCAP $96M and a mining $37M into Q1’26), each described as “isolated,” none of which is. Second, the top line is not growing — revenue is flat-to-down five years running, 2025 book-to-bill was 0.77x, backlog fell ~10%, and Energy Solutions new awards collapsed from $6.9B (2023) to $1.4B (2025). Third, the buyback that is driving per-share optics is funded by a one-time windfall, not recurring free cash flow, insiders have bought exactly zero shares in the open market, and executive comp contains no return-on-capital metric at all.

At ~$53 the market is paying for the base-to-bull outcome — margin normalization and backlog conversion and no repeat of the charge pattern, three things that must go right simultaneously — and is not discounting the historical base rate of the fourth thing going wrong. Framing: this is a crowded, high-beta (1.51) momentum re-rating (Momentum loading +0.48; last-quarter move +56% annualized; YTD +34%) on a still-structurally-mediocre business, not the early innings of a durable quality re-rating.

Conviction: medium. Catchy tag: “The survivor’s victory lap — priced as if the charges are over.” The single piece of evidence that flips me bullish: two-plus consecutive clean quarters of the promised margin step-up (Urban >3.5%, Energy >6%) with book-to-bill durably >1 and no new charge — proof the reimbursable pivot finally shows up in earnings, not just in slides. The single piece that flips me more bearish: another material project charge or an Urban-margin guide cut, confirming the cadence is structural, not legacy.

📈 Stock Price Action — Five-Year Event Map

Factual five-year price history and the events that drove it. Price moves are FACT; attributed causes are INTERPRETATION. No recommendation, no price target, no support/resistance levels.

Arc. Fluor round-tripped a full cycle. From a ~5-year low of $14.60 (21-Sep-2021) — the wreckage of the 2019–20 accounting restatement — it re-rated ~4x to an all-time high of $58.93 (07-Nov-2024) on the NuScale/nuclear narrative, gave back a third to $39.63 (year-end 2025) on the Santos charge and weak awards, and has rallied back to $53.26 (23-Jul-2026), ~10% below its high, near the top of its 52-week range ($37.62–$57.50), +34% YTD.

Cycle narrative. The stock’s floor was set by survival, not fundamentals — the 2021 low priced real going-concern risk after the restatement. The 2022–23 recovery was “the company will live” plus the emergence of NuScale as a hidden asset. 2024 was the turnaround re-rate turbocharged by the nuclear/SMR narrative, with a GAAP EPS of $12.33 that was ~90% a non-cash NuScale mark. 2025 delivered the reality check: the Santos judgment and a sub-1.0 book-to-bill reminded the market this is a charge-prone contractor. 2026 is a narrative-plus-buyback rally — the NuScale cash monetized the last hidden asset and funds the float shrink, while a parade of front-end awards (LNG Canada Phase 2, Centrus, power) rekindled the pick-and-shovel story, briefly interrupted by the 15% Q1-miss drop before recovering to $53.

1. Executive Summary

Fluor Corporation is one of the world’s largest publicly-traded engineering, procurement and construction (E&C) firms — an asset-light, ~23,000-person organization that designs, procures and builds large industrial and infrastructure projects across three segments: Urban Solutions (infrastructure, advanced technologies/data centers, life sciences, mining & metals), Energy Solutions (oil & gas, chemicals, LNG, power, energy transition, nuclear), and Mission Solutions (US government, nuclear security, environmental remediation). FY2025 revenue was $15.5B against a total backlog of $25.5B.

The investment debate is not about whether Fluor will survive — that question was answered in 2022 — but about what it is worth now that it has. Our conclusion across every workstream is consistent: Fluor is a structurally low-margin, low-return, charge-prone business that has meaningfully de-risked its balance sheet and contract mix but not its earnings quality. Through the cycle, adjusted segment-EBIT margin is only ~3.3–3.5% on gross revenue (a flattering ~8–9% on the roughly half of revenue that is fee-bearing rather than pass-through), adjusted EBITDA is a stable ~$500–560M, and normalized return on equity clears a ~10–12% cost of equity only in charge-free years — of which there are very few. In FY2025 a single legacy fixed-price project (Santos, completed 2015) produced a $643M revenue reversal that erased two years of segment profit and turned operating cash flow negative.

Against that, three real positives: (1) the NuScale monetization — a decade-old ~$100M venture stake harvested for ~$2.4B, a genuine capital-allocation win that leaves Fluor with net cash; (2) the reimbursable pivot — 81% of backlog and 87% of new awards are now cost-reimbursable, structurally shrinking the fixed-price blow-up risk of the last cycle; and (3) a credible demand backdrop — nuclear/SMR, LNG, data-center power, copper/critical minerals, and US onshoring.

The tension is valuation. Fluor trades at its own richest-ever multiple on sales (99.7th percentile) and ~2.5x book, and on forward numbers (~$2.70 adjusted EPS, ~$540M adjusted EBITDA) at ~19–20x P/E and ~9x EV/EBITDA. It is cheaper than peers on EV/EBITDA — correctly, because its margins and returns are the worst of the group (EMCOR earns ~9% operating margin and 31% ROIC; Fluor earns ~3% and low-single-digit ROIC). The market is underwriting a permanent margin step-up layered on a backlog supercycle, while the top line is flat, book-to-bill is below 1.0, and the charge cadence continues. This memo takes no position and sets no price target; it lays out what must be true for the current price to be right, and what would falsify each side.

2. Business Overview

What Fluor does. Fluor is a project-delivery company. It sells engineering hours, procurement scale, construction management, and (increasingly less) self-perform construction to owners of large capital assets — oil & gas majors, national oil companies, mining houses, governments, utilities, life-sciences and technology companies. It does not own the assets it builds; its capital base is small (capex is <0.4% of revenue), and its balance sheet is dominated by working capital, cash, and a modest debt stack. Revenue is project-based and non-recurring: backlog burns at roughly 50% per year, so about half of the $25.5B year-end 2025 backlog converts to 2026 revenue, and forward visibility beyond ~12–18 months is limited.

Segments (FY2025). Fluor reorganized into three client-facing segments in 2024:

(Segment revenue for Urban is derived as the residual; segment profit is a non-GAAP measure Fluor uses to manage the business. Source: FY2025 10-K, MD&A and segment note.)

The central facts of the business model. (1) About half of Fluor’s revenue is zero-margin pass-through — procured equipment, materials, and subcontracted craft labor that flow through the top line at cost. FY2025 at-cost revenue was ~$8B (~53% of the $15.5B GAAP total; ~$7B/40% in FY2024). Fee-bearing “adjusted net revenue” was ~$7.5B. This is why headline margins look so thin and why the top line is a poor gauge of value capture. (2) Contract mix is now 81% reimbursable ($20,713M of $25,536M backlog; new awards 87% reimbursable; Q1’26 awards 98%). Under reimbursable/cost-plus contracts Fluor bears far less cost-overrun risk than under lump-sum/fixed-price — the post-2020 de-risking is real and quantified. (3) The book is shrinking: total backlog fell ~10% YoY, and 2025 new awards of $11,956M against $15,503M revenue imply a book-to-bill of just 0.77x. (4) The geographic mix is shifting home: backlog outside the US fell to 40% (from 55%), and only 26% of 2025 new awards were non-US (76% in 2023) — Fluor is increasingly levered to US reshoring, data-center, and DOE demand.

Customers and revenue nature. End markets are cyclical capital-spending programs: energy, chemicals, mining, infrastructure, and government. A single Urban Solutions customer represented 15% of 2025 revenue (customer concentration is a live risk; see the Risk Analysis). Revenue recognition is percentage-of-completion, which means estimates of cost-to-complete drive reported profit — and adverse revisions produce the charge cadence that defines Fluor’s earnings history.

3. Industry Dynamics

Structure. Global E&C is a structurally unattractive industry, and Fluor sits in its least attractive niche. The business is capital-light, which sounds appealing but means low barriers to entry — anyone with engineers and a balance sheet can bid. Buyers are few, large, and sophisticated (energy majors, national oil companies, governments, mega-cap technology firms), conferring substantial buyer power. Work is awarded through competitive tender, frequently to the lowest bidder, which invites the winner’s curse: the firm that most underestimates cost wins the job and books the loss. The result is chronically thin profit pools — mid-single-digit operating margins for the best-run self-performers and low-single-digit for lump-sum megaproject managers like Fluor.

Profit pools and where value accrues. The margin hierarchy within E&C is instructive. Self-performing specialty trades (EMCOR, Quanta, MasTec) own skilled craft labor with local density; in a tight-labor cycle that labor scarcity confers pricing power, and these firms earn 5–9%+ operating margins and mid-teens-to-30% returns on capital. Asset-light professional services / program management / government services (Jacobs, AECOM, KBR) shed self-perform construction risk and earn 6–9% margins on a services model. Lump-sum megaproject EPC — Fluor’s historical core — is the worst niche: giant fixed-price energy and infrastructure jobs with uncapped cost-overrun tails, ~90% pass-through content, no operating leverage, and multi-year execution windows during which any of a hundred things (subcontractor design errors, escalation, schedule, weather, force majeure, client disputes) can turn a thin fee into a large loss.

Demand super-cycle (real). Cutting the other way, a genuine multi-year demand wave is flooding into the sector: data centers and semiconductors, LNG, nuclear (large-scale and SMR), critical minerals and mining, grid modernization, and US onshoring of advanced manufacturing (life sciences, rare-earth magnets, chips). Fluor is a credible participant in all of these, and management’s front-end pipeline is broad and expanding. The demand backdrop is the strongest it has been in a decade.

Capital-cycle read (Marathon lens). The binding capacity constraint in E&C is not plant — it is skilled craft and engineering labor. That scarcity is a supply-side tailwind for firms that own the labor (the self-performers) and a headwind for asset-light EPC managers like Fluor, which must subcontract into the same tight labor market at escalating cost — precisely the mechanism behind the FY2025 infrastructure charges. A hot cycle lifts every contractor’s backlog, but it does not repair Fluor’s structural margin gap; historically it has re-tempted Fluor into risky fixed-price work (the 2019–20 trap). Capital is not flooding into E&C capacity (it is asset-light), but it is flooding into the equities — which is the valuation story, not the business story.

Verdict: a structurally bad industry riding a real demand cycle. The cycle is genuine and durable; the profit pools are thin, contested, and — for lump-sum megaproject work specifically — asymmetric to the downside. A good industry rewards incumbency with pricing power and stable high returns; E&C rewards it with the right to bid again. Structurally unattractive.

4. Competitive Position

Does Fluor have a moat? No. Fluor’s competitive position fails the moat test on its own terms: the financial outcome a moat is supposed to protect — margins and returns on capital — is already at or below the cost of capital, so there is no economic moat doing load-bearing work. In Greenwald’s taxonomy:

• Scale economies: absent. Project cost is ~90% pass-through (equipment, materials, subcontracted labor), not leveraged fixed cost. Being larger does not lower Fluor’s cost per unit of output in a way that competitors cannot match; each megaproject is priced on its own.
• Switching costs: absent. Each project is competitively re-bid; clients routinely multi-source and split scopes across contractors. There is no installed base, no recurring service annuity, no lock-in.
• Network effects: absent.
• Intangibles (the only candidate): narrow and real only in Mission Solutions — DOE and national-security clearances, past-performance credentials, and qualification-based selection for nuclear and government work create a genuine, if limited, barrier. This is the one place Fluor has something defensible, and it is the segment least exposed to the commodity-bidding dynamic. It is not enough to re-rate the whole company.

Peer comparison — the gap is business model, not skill. Fluor is the worst of the entire peer set on both operating margin and return on capital:

(FY25 operating margin and returns per ROIC.ai; Fluor’s FY25 is charge-distorted, but even normalized it is the lowest — normalized segment margin ~3.3–3.5%, normalized ROE ~9–11% in a clean year. Fluor’s reported FY24 ROE of +104% and net margin of +13% are artifacts of the one-time NuScale gain, not real earning power.)

Why does EMCOR earn ~9% and Fluor ~2%? Not because EMCOR executes better — because EMCOR sells a different, better business. Self-performers capture the labor-scarcity premium; services firms capture the design/program-management margin without the construction tail; Fluor stayed in lump-sum megaproject EPC longest, the niche with the worst risk-adjusted economics. The reimbursable pivot removes the left tail but also caps the upside at low-single-digit cost-plus fees. Fluor is trading a chance at occasional feast-and-famine for reliable thin gruel — prudent for survival, but not a route to a moat.

Verdict: no durable competitive advantage; a crowded, commoditized, charge-prone contractor with one narrow qualification-based niche (Mission). The “moat” claims one hears — scale, relationships, technical capability — cannot be tied to a financial outcome that would deteriorate without them, because the outcome (margins/ROIC) is already poor. That is the definition of the absence of a moat.

5. Growth History and Forward Opportunities

History: not a growth company. Revenue has drifted sideways for half a decade — $14.2B (2020), $13.7B (2022), $15.5B (2023), $16.3B (2024), $15.5B (2025). What looks like “growth” in any given year is backlog-conversion timing on a lumpy megaproject book, not compounding. The one clear trend is mix: Urban Solutions has grown to ~60% of revenue and ~74% of backlog — and it is the thinnest-margin segment (FY26 guided 2.5–3.5%).

New-award momentum: weak and lumpy. 2025 new awards were only ~$12.0B (book-to-bill 0.77x), and Energy Solutions awards collapsed from $6.9B (2023) to $3.2B (2024) to $1.4B (2025) — a genuine air-pocket, whether from bid discipline (walking from bad fixed-price work) or demand hesitancy (trade/geopolitical uncertainty, the SRPPF tendering delay). Q1’26 awards were just $2.7B (98% reimbursable), and management insists full-year 2026 book-to-bill will exceed 1.0, back-half weighted — an assumption, not yet a fact.

Forward opportunities (the bull’s exhibit). The 2026 front-end award flow is broad and real, and it is where the pick-and-shovel narrative lives:

• LNG Canada Phase 2 — JGC Fluor JV received a limited notice to proceed (01-Jun-2026); CEO Breuer sizes the eventual EPC at “$5–10B.”
• Aramco — long-term agreement signed (07-Jul-2026).
• Centrus uranium-enrichment FEED, with EPC to follow (H2’26/2027) — leverages the Mission/nuclear franchise.
• Woodsmith (Anglo American) fertilizer-mine feasibility (07-May-2026); America First Refinery FEED (first US grassroots refinery in ~50 years); Bahrain petrochemical FEED (21-Jul-2026).
• X-energy/Dow SMR at Seadrift; TeraWulf 480MW data-center LNTP (Kentucky); CTA Red-Purple Line reached substantial completion (01-Jul-2026).

Management claims >$60B of in-house front-end work convertible to backlog plus ~$40B of further prospects, with the pipeline up ~50% YoY. Two caveats bite hard: (1) the marquee data-center dollars are contested — Breuer concedes Fluor is “a little behind” and that risk-allocation terms remain unattractive, steering Fluor toward power rather than the DC shell; and (2) most big 2026 awards are front-end (FEED/feasibility) — low-revenue options on client final investment decisions, not booked EPC. A pipeline of options is worth less than a backlog of contracts.

Verdict: low-to-medium-quality growth. New-award margins are running ~200bps above the backlog average (a genuine positive), and the reimbursable shift lowers charge risk. But top-line growth is modest, concentrated in the lowest-margin segment, dependent on FEED-to-FID conversion that has not yet happened, and set against a shrinking book. Quality is improving at the margin; it is not yet high.

6. Financial Quality

GAAP is noise; you must normalize. Fluor’s reported earnings are among the least representative in our coverage. The two anchor distortions:

• FY2024 reported net income of $2,145M / EPS $12.33 is ~90% non-operating. Equity-method earnings were ~$2,105M pretax (~$1,729M after-tax ≈ 81% of net income), dominated by the NuScale deconsolidation (Oct-2024) and revaluation. The large $634M tax line is the cost of that gain, not a benefit. GAAP operating income was only $384M; “clean” 2024 operating net income was ~$150–200M, and even that leaned on ~$150M of interest income and ~$92M of FX. Normalized FY24 EPS was ~$2.32, not $12.33.
• FY2025 GAAP net loss of −$51M / EPS −$0.31 vs. adjusted EPS of $2.19. The bridge: Santos $643M (an Australian LNG project completed 2015; an adverse judgment booked as a reversal of previously recognized revenue, hitting Energy; net of committed insurance = cash paid Q4’25; appeal mid-2026); $108M of cost growth on three infrastructure projects (Urban; subcontractor design errors and escalation), partly offset by $54M favorable; $60M in Mission (DoD disputed-cost reserves + a $28M adverse ruling on a 2019 project); $43M restructuring; −$62M FX. Santos alone erased roughly two years of segment profit.

Normalized earnings power. Stripping the noise, Fluor is a stable ~$500–560M adjusted-EBITDA business:

Through-cycle normalized total segment profit is ~$600–700M; less ~$155M of run-rate corporate G&A, segment-EBIT is ~$500–545M, which ties to management’s adjusted EBITDA (FY25 $504M, FY24 $530M, FY26 guide $525–560M). True through-cycle EBIT margin on gross revenue is only ~3.3–3.5%. On the ~$7.5B of fee-bearing net revenue, normalized margin is a healthier ~8–9% — the “real” economics, and the number the bull case should quote.

Cash flow quality: thin and one-off-driven. Operating cash flow was +$212M (FY23), +$828M (FY24), and −$387M (FY25). The FY25 burn is the ~$642M Santos cash payment; ex-Santos, OCF was ~+$255M — still understated by a further ~$191M of loss-project/JV funding that sits in investing cash flow through the JV structure. Three-year cumulative OCF is ~$653M (~$218M/yr) — volatile, advance-payment- and working-capital-driven, and not steadily backing the ~$500M adjusted EBITDA. Capex is trivial (~$50M, <0.4% of sales) — genuinely asset-light. Crucially, the $754M FY25 → ~$1.4B FY26 buyback is funded by NuScale proceeds, not operations.

Balance sheet: genuinely strong; book value is real. Cash and securities ~$2.2B; total debt ~$1,070M ($543M 2028 notes + a $575M 1.125% 2029 convertible, strike $45.37) → net cash of ~$1.1B ex-NuScale and ~$2.6B including the held-for-sale NuScale position monetized in Q1/Q2’26. Equity is $3,244M / 152.0M shares = BVPS $21.34 (Q1’26 $20.28). Note: a third-party feed (AZI) shows BVPS of $16.32, which does not reconcile to the filing; we use the filing figure — true P/B is therefore ~2.5x, not the ~3.3x that feed implies. No near-term maturities; the only covenant collateral trigger is a one-notch downgrade.

Returns on capital — the honest read. Normalized NOPAT (~$365M) on a very small operating-capital base makes ROIC screen high (~15–20%) — but that is a negative-working-capital float artifact (client advances funding the business), not durable earning power. On the $3.2B equity base, normalized ROE is ~9–11% in a clean year and deeply negative in a charge year (FY21, FY25). Through the cycle, Fluor barely clears, and frequently misses, a ~10–12% cost of equity — the worst returns of the peer set.

Verdict: economics do not improve with scale, and Fluor earns its cost of capital only intermittently. The asset-light, net-cash, reimbursable-shifted business is a real improvement on 2019–20, but a single legacy project can and did erase two years of profit and turn cash flow negative. This is a low-return business with a high-tail-risk earnings profile — not one whose per-unit economics compound.

7. Capital Allocation

The NuScale monetization — a genuine win. Fluor invested in NuScale in 2011 (a ~$100M+ venture stake), rode it through a 2022 de-SPAC and the 2023–24 SMR mania, and exited entirely in structured tranches: ~$605M net in 2025 (converting 15M voting shares), ~$1.35B on 13-Feb-2026 (a 71M-share variable-price forward), and the remaining ~40M shares across April 2026 — a cumulative ~$2.43B, roughly 4.5x MOIC and a ~15% IRR over 14 years. Timing the exit into a hot SMR market was first-rate. (NuScale was deconsolidated Oct-2024 and held at fair value thereafter, so its marks ran through P&L — the source of the GAAP noise in Financial Quality. The exact booked gain vs. cost basis reconciles to the Q2-2026 10-Q, not yet filed — an open item.)

Buybacks — funded by the windfall, executed near record valuations. Capital return is now 100% buyback (no common dividend since April 2020):

The Board expanded the authorization by 30M shares in Feb-2026 (to 96M cumulative since 2011). The concern is textbook Marathon “buying high”: Fluor is repurchasing at a P/S near the richest in its history, and it accelerated into a Q1’26 earnings miss. One sell-side note read the buyback as “neutral … signals limited reinvestment opportunities.” The buyback is the primary per-share value lever, and its wisdom rests entirely on whether ~$45–50 proves cheap in hindsight — an open question, not an established win.

Portfolio: disposal-heavy and disciplined. Fluor has pruned to a reimbursable core — ICA-Fluor Daniel (Mexico JV) sold to partner ICA for $175M (16-Jul-2026); Stork fully divested (2024–25); AMECO divested (2023); a China fab yard (CFHI) sold. The $600M convertible preferred issued in the 2020 crisis mandatorily converted in Sept-2023 (with a $27M cash make-whole) and is retired. No sizeable acquisitions — a deliberate shrink-to-core posture, which we view favorably given the industry’s M&A track record.

Incentives — the key governance tell: no return-on-capital metric. The 2025 annual incentive plan for corporate NEOs weighted EBITDA 35% / Cash Flow from Segments 35% / Safety 10% / Strategic 20%; 2026 sensibly adds New Awards Gross Margin 10% (rewarding award quality). Long-term performance awards (50% of LTI) pay on 3-year average EBT and relative TSR vs. the S&P 500. There is no explicit ROIC or return-on-capital metric anywhere in the pay plan — management is paid on profit, cash flow, award quality, safety, and relative TSR, not on returns per unit of capital. For a business whose entire problem is thin returns on capital, that is a meaningful omission; relative TSR is the only per-share alignment lever.

Insiders — zero conviction. A full parse of the FY25–26 Form 4 corpus shows zero open-market purchases (code P) by any insider. Activity is entirely routine grants (A), RSU/PA settlement (M), sell-to-cover (S), and tax withholding (F): CEO Breuer (F 26,805, no buys), CFO Regan (S/M/F), retiring ex-CEO Constable (large diversification sells). Not alarming, but notable: with the stock ~26% off its high earlier in 2026 and management touting a bright pipeline, not one insider bought a share in the open market. They buy back stock corporately, not personally.

Verdict: mixed-to-favorable, with a real caveat. The NuScale harvest and disciplined divestitures are genuine strengths. But recycling a one-time windfall into buybacks at a near-record multiple, the absence of any ROIC metric in comp, no dividend, and zero insider buying temper the enthusiasm. Capital-allocation adequacy is established; brilliance is unproven and depends on the buyback price.

8. Changes and Headwinds — Last Two Years

Strategy reset under new-but-internal leadership. CEO James Breuer (a Fluor lifer since 1993, COO 2024–25) took over effective 1-May-2025, with CFO John Regan effective 1-Mar-2025; ex-CEO David Constable retired as Executive Chairman at the 6-May-2026 AGM. Breuer reframed the company from “fix-and-build” to “grow-and-execute” — grow backlog, execute cleanly, return cash. The substantive change is the contract-mix pivot (81% reimbursable backlog, 87–98% reimbursable new awards; lump-sum reserved for “smart,” risk-shared, post-FEED conversions), which structurally lowers the fixed-price blow-up risk that nearly killed the company.

Portfolio simplification (complete). NuScale fully monetized (~$2.4B); AMECO, Stork, the CFHI China yard, and the ICA-Fluor Mexico JV all divested. The balance sheet is clean and net cash. The “asset-light journey” is, by management’s own framing, essentially done.

The recurring-charge problem (the crux). The “we’ve de-risked” narrative is undercut nearly every quarter. FY2025: Santos $643M, $108M infrastructure cost growth, $60M Mission/DoD reserves, $43M restructuring — a GAAP segment loss and negative OCF. Q1’26: a $37M mining charge (Americas project, ~80% complete) and a $96M LOGCAP (Afghanistan) legal loss (treble damages + fees; appealing). Reko Diq (Pakistan copper) is being slowed by the client on security grounds. Each charge is described as isolated; the pattern is not, and the litigation tail (Santos appeal mid-2026, LOGCAP appeal) is a live 2026–27 overhang.

Verdict: mixed — modestly thesis-strengthening on structure, thesis-weakening on execution credibility. The reimbursable pivot, NuScale cash, and buyback are real de-risking. But because the P&L has not yet delivered a clean, charge-free year, the market is being asked to take the margin step-up on faith. Until two or three consecutive clean quarters arrive, the changes strengthen the balance sheet more than the earnings thesis.

9. Risk Analysis

Chance of a total loss: low. Net cash, asset-light, no near-term maturities, and a reimbursable-heavy book make a repeat of the 2019–20 solvency scare unlikely. The dominant risks are earnings and valuation risks — charges, a failed margin step-up, and de-rating from a record multiple — not solvency.

10. Valuation Discussion (Embedded Expectations)

Where it trades. $53.26; market cap ~$7.2–7.4B; net cash ~$1.1B ex-NuScale (~$2.6B including the monetized held-for-sale position) → EV ~$5B. Trailing EV/EBITDA is meaningless (TTM EBITDA is negative on the charges). On FY26 guided adjusted EBITDA (~$542M midpoint), forward EV/EBITDA ≈ 9x; on FY26 adjusted EPS ($2.60–2.80), forward P/E ≈ 19–20x. The single most important valuation datum is own-history: P/S 0.62x = 99.7th percentile (richest ever on sales), P/B ~2.5x (87.6th percentile per the same feed), composite 81st percentile. On sales, the stock has never been more expensive.

Peer comps (ROIC.ai TTM, EV/EBITDA):

Fluor trades at a steep discount to peers on EV/EBITDA and a massive discount on EV/Sales — correctly. Its margins are structurally the lowest, its returns the worst, and its charge history the ugliest. The valuation puzzle is not cross-sectional cheapness; it is that Fluor sits at its own richest-ever P/S while better-margin, cleaner-record peers (ACM, KBR) trade at similar or lower EV/EBITDA.

What the market is underwriting. To justify ~$53, the market must be pricing a permanent margin step-up (Urban 2–3% → mid-single-digit; Energy back to 5–6%; “smart lump sum” power work at real margins) layered on a secular backlog super-cycle — i.e., the 2028 targets hit on schedule with no repeat of the Santos/mining/LOGCAP charge pattern. That is three favorable outcomes at once.

Scenario analysis — FY2028 (illustrative, assumption-heavy; not a target). Shares ~120M post-buyback; net cash ~$1.5B:

*Blend of EV/EBITDA (+net cash) and P/E lenses. Read-through: the current ~$53 sits at or near the base case — the market is already paying for margin normalization plus backlog conversion. The bull case requires the super-cycle to convert and margins to durably step up and charges to stop — simultaneously. The bear case (charges persist, Urban stuck ~3%, awards slip) implies material downside and is essentially unpriced. The embedded expectation is base-to-bull, with the historical charge-recurrence probability not discounted. No price target.

11. Variant Perception

Consensus. ~Moderate Buy (~8 analysts). The sell-side and retail framing (Fool, Seeking Alpha, Zacks) is “nuclear + data-center + onshoring pick-and-shovel with a clean balance sheet and a huge buyback.” One notable post-Q1 downgrade (“Too Many Headwinds Emerging”); a value-screen service (GF Value) flags the stock as above fair value.

Strongest bull case. A reimbursable-heavy backlog plus NuScale cash plus a ~$1.4B buyback (11% float cut in 2025, more to come) shrink the share count into a genuine multi-year award super-cycle (LNG, nuclear fuels, copper, power). Margins inflect as “smart lump sum” and services-rich front-end work (200bps above backlog) convert. A capital-light, net-cash E&C compounding FCF and buying back stock re-rates toward peers.

Strongest bear case. This is a structurally low-margin, charge-prone contractor whose P&L has never validated the margin story — Santos, mining, infrastructure, and LOGCAP charges recur every 1–2 quarters. Revenue is flat, “growth” is thin Urban volume, the data-center prize is going to regional contractors, and the marquee awards are unconverted FEED options. At the richest P/S in its history with a lifetime total return near zero, the buyback is the only real value lever — and it is funded by a one-time NuScale windfall, not recurring FCF.

The 3–5 assumptions that matter most (with falsification tests):

1. Reported margins step up (Urban >3.5%, Energy >6%) without new charges. Falsifier: another material charge in FY26–27, or an Urban-margin guide cut.
2. Book-to-bill stays >1 and FEED options convert to EPC FIDs (LNG Canada Ph2, Centrus EPC, power). Falsifier: FID slippage or an awards miss in H2’26.
3. The reimbursable mix is durable as Fluor chases lump-sum-friendly power/DC work. Falsifier: a large fixed-price EPC re-entry that reintroduces tail risk.
4. Buyback-driven EPS growth is sustainable once the NuScale cash is spent. Falsifier: FCF fails to fund continued repurchase beyond 2026.
5. Litigation tails resolve without further cash bleed (Santos appeal, LOGCAP appeal).

Factor-positioning read (input, not a call). Fluor is a high-beta (1.51) momentum vehicle — FactorsToday Base loadings show Market +1.15, Momentum +0.48, with strong recent thrust (last-quarter move +56% annualized, Sharpe ~1.0; 6-month relative strength +24%; YTD +34%) — but 12-month relative strength is −1.4% (a round-trip, not a trend). The long record is damning: lifetime return ~+1.75%/yr, maximum drawdown −95.9%, trailing-year −4.3%. This is a stock that has repriced up and down the same slope for a decade. The factor loadings say “high-beta, liquidity-sensitive cyclical riding a narrative,” not “quality compounder.” For the bull thesis to be right, the current move must be an early re-rating on a durably better business; the factor history says the base rate for that is low. Treat this as evidence that consensus may be offsides on durability — not as a directional prediction.

12. Fact vs. Interpretation Table

13. Open Questions

1. Exact cumulative NuScale cash proceeds and booked gain vs. cost basis — reconcile to the Q2-2026 10-Q (not yet filed).
2. What was the reimbursable share of revenue recognized in 2025? The 10-K gives the backlog split (81%), not a clean revenue split.
3. Is the Q1’26 Energy margin of 10.5% sustainable, or flattered by three one-time project close-outs?
4. Is book-to-bill 0.77x / backlog −10% a demand air-pocket or deliberate bid discipline (walking from bad fixed-price work)?
5. What are the precise 2028 investor-day adjusted-EBITDA/margin targets (not in the transcripts read)?
6. Santos appeal and insurance-clawback optionality (mid-2026) — quantum and probability.
7. The AZI BVPS discrepancy ($16.32 vs. the filing’s $21.34) — resolved in favor of the filing here; worth monitoring the feed.

14. What Must Be True

For the bull case (buy-and-hold at ~$53 works):

• Reported segment margins step up durably — Urban to 3.5%+, Energy to 5–6% — without a new material charge, for multiple consecutive quarters.
• 2026–28 book-to-bill exceeds 1.0 and the marquee FEED awards (LNG Canada Ph2, Centrus, power) convert to booked EPC FIDs.
• Free cash flow ramps toward the ~$500M adjusted EBITDA so the buyback becomes self-funding after the NuScale cash is spent.
• Falsification test: any material project charge, an Urban-margin guide cut, or an H2’26 awards miss. One clean quarter is not enough; the bull case needs the charge cadence to visibly break.

For the bear case (the re-rating reverses):

• The margin step-up fails to appear in reported numbers, and at least one more Santos/mining/LOGCAP-style charge lands within 12–18 months.
• Book-to-bill stays below 1.0, backlog continues to shrink, and the FEED pipeline does not convert on schedule.
• The buyback decelerates once NuScale cash is exhausted, removing the per-share prop, and the P/S de-rates from the 99.7th percentile toward its own median.
• Falsification test: two-plus consecutive clean, charge-free quarters with rising reported segment margins and book-to-bill durably >1 — which would prove the reimbursable pivot has genuinely changed the earnings profile, not just the balance sheet.

15. Source Appendix

See Appendix B — Source Appendix below for the full source list with URLs and access dates. Primary sources: Fluor FY2025 10-K (filed 2026-02-17), FY2024/FY2023/FY2022 10-Ks, Q1-2026 10-Q, DEF 14A proxy (12-Mar-2026), Form 4 corpus, Q1-2026 and Q4-2025 earnings-call transcripts, and Fluor press releases (BusinessWire). Quantitative cross-checks: ROIC.ai (statements, EV, peer ratios), AZI valuation_index (own-history percentiles) and price CSV, FactorsToday (factor loadings and risk-adjusted track record). Secondary: Zacks, Motley Fool, Seeking Alpha, Benzinga, GuruFocus, MarketBeat (used for triage and confirmed against primary sources).

Sections 1–15 carry no investment recommendation and no price target; the Author’s Take block is a separate, clearly-labeled subjective opinion. This article is general information, not investment advice.

APPENDIX A — Standard Diligence Questionnaire — Fluor Corporation (NYSE: FLR)

Supplemental to the research note. Fact/Interpretation/Assumption labeled where it matters.

General

What thoughtful questions have other investors asked about this company? The recurring institutional questions: (1) Is the reimbursable pivot real, or does the fixed-price tail keep bleeding? (Answer per our work: the new book is genuinely de-risked at 81% reimbursable, but legacy fixed-price charges — Santos, infrastructure — keep landing.) (2) Is NuScale cash a one-time sugar high funding buybacks at the top? (3) Can Urban margins actually reach the 3.5%+ guide? (4) Is Fluor a credible data-center winner, or is that dollar going to regional/self-perform contractors? (5) What is normalized earnings power once the GAAP noise (NuScale marks, charges, tax) is stripped — our answer: ~$500–560M adjusted EBITDA, ~$2.20–2.80 adjusted EPS.

Cyclicality & Earnings Nature

Cyclical high or low? Neither extreme. Revenue is flat-to-down five years running; margins are below a clean-year normal because of FY25 charges, so reported earnings are near a cyclical/charge low while demand (awards pipeline) is arguably near a cyclical high — a divergence. Driven by external environment or internal actions? Both: demand is external (energy/infra capex cycle); the charge cadence and margin level are internal (execution and contract selection). Revenue stability? Low — project-based, ~50% annual backlog burn, lumpy mega-awards, and adverse percentage-of-completion revisions. Market size/direction? The end markets (nuclear/SMR, LNG, data-center power, copper, onshoring) are growing; Fluor’s share of value within them is thin because ~half of revenue is pass-through. International vs. domestic: shifting sharply domestic (non-US backlog fell to 40% from 55%).

Business Quality & Competitive Moat

Industry more or less competitive? Persistently competitive; low barriers to entry, sophisticated buyers, competitive tender. How profitable (ROIC, ROE)? Poor — normalized ROE ~9–11% in a clean year, negative in a charge year; screened ROIC is a negative-working-capital float artifact, not durable. Worst of the peer set. How profitable is the industry? Thin profit pools; the best economics accrue to self-performers (EMCOR ~9% margin, 31% ROIC) and services firms (Jacobs/AECOM/KBR 6–9%), not lump-sum EPC managers. Easily understood? Yes conceptually, but the accounting (percentage-of-completion, equity-method NuScale, one-time charges) is hard to normalize. Undermined by low-cost foreign labor? Partly — Fluor uses global-execution/low-cost engineering centers, a cost lever, but the tight craft labor market is a cost headwind. Do brands matter? Marginally — reputation/past-performance matters for qualification (especially DOE/nuclear/Mission), but does not command price premia in competitive tender. Nature of competition? Price and qualification-based bidding. Switching costs? Effectively none; each project re-bid.

Financial Condition & Balance Sheet

Assets not fully on the balance sheet? The Mission/nuclear qualifications and DOE relationships (intangible, unrecognized); JV interests are equity-accounted. Off-balance-sheet liabilities? Project guarantees, surety bonds, JV funding obligations, and litigation contingencies (Santos appeal, LOGCAP) — material and a genuine risk. How conservative is the accounting? Percentage-of-completion inherently relies on cost-to-complete estimates; the repeated adverse revisions suggest estimates have not been conservative on legacy fixed-price work. CapEx-hungry? No — genuinely asset-light (capex <0.4% of sales).

Capital Allocation & Management

FCF generation and use? Volatile (~$218M/yr 3-yr average OCF, and negative in FY25 on Santos); capital return is 100% buyback, currently funded by the NuScale windfall rather than operations. Philosophy? Shrink-to-core, net-cash balance sheet, return excess via repurchase; no dividend since April 2020. Significant acquisitions? None recently — the opposite; a string of divestitures (ICA-Fluor $175M, Stork, AMECO, CFHI). Buying back shares? Yes aggressively — ~$754M (2025, ~11% float), ~$1.4B target (2026) — at a near-record P/S (a Marathon “buying-high” flag). Issuing shares to insiders? Routine equity comp only; no large dilutive issuance (the $600M convert retired 2023). Compensation policy / motivations? AIP on EBITDA/Cash Flow/Safety/Strategic (+New Awards Gross Margin in 2026); LTI on 3-yr avg EBT + relative TSR. No ROIC metric — a governance gap for a low-return business. New CEO (Breuer, internal lifer, eff. 1-May-2025) and CFO (Regan, eff. 1-Mar-2025).

Valuation & Market Data

ADR/MLP/K-1? No — US common stock, NYSE, standard 1099. Dividend policy? None (suspended April 2020; not reinstated). How profitable? Low-margin, low-return (see above). Net income diverging from cash from operations? Yes, severely and in both directions — FY24 GAAP net income $2.1B vs OCF $828M (NuScale non-cash gain inflated NI); FY25 GAAP loss −$51M vs OCF −$387M (Santos cash payment). Neither year’s net income represents cash earning power; normalize to ~$500M adjusted EBITDA.

Risks & Downside

What would cause the stock to decline? A new material project charge; a margin-guide cut; an awards/book-to-bill miss; exhaustion of the NuScale buyback fuel; a de-rating from the 99.7th-percentile P/S; adverse litigation (Santos/LOGCAP). Catastrophic loss risk? Low — net cash, asset-light, no near-term maturities, reimbursable-heavy book; the 2019–20 solvency scenario is structurally much less likely. Total loss? Very low probability given the balance sheet. The realistic downside is a valuation de-rating plus continued thin/charge-impaired earnings, not insolvency.

Recent News & Events

Business environment changed recently? Yes — a broad front-end award cycle in 2026 (LNG Canada Phase 2 LNTP, Aramco LTA, Centrus enrichment, Woodsmith, Bahrain, TeraWulf data-center, America First Refinery) and the completion of NuScale monetization. Significant acquisitions? No — divestiture of ICA-Fluor Mexico JV ($175M, July 2026). Accounting-policy changes? None material beyond the 2024 segment reorganization and NuScale deconsolidation (Oct 2024). Recent changes — markets, facilities, management? New CEO/CFO (2025); “grow-and-execute” strategy; sharper US/domestic tilt; nuclear-fuels (Centrus) and SMR (X-energy/Dow) entries; Q1’26 earnings miss on legal + mining charges.

APPENDIX B — Source Appendix — Fluor Corporation (NYSE: FLR)

Report date 2026-07-24. Primary sources first. All URLs accessed 2026-07-24 unless noted.

Primary — SEC Filings (mirrored locally in output/FLR/sources/)

1. Fluor Corporation FY2025 Form 10-K, filed 2026-02-17 (flr-20251231.htm) — segment revenue/profit, backlog, new-awards table, Santos charge, contract-mix, balance sheet. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001124198&type=10-K
2. FY2024 Form 10-K, filed 2025-02-18 (flr-20241231.htm) — NuScale deconsolidation, 2024 equity-method gain, tax.
3. FY2023 Form 10-K, filed 2024-02-20; FY2022 Form 10-K, filed 2023-02-21 — multi-year segment normalization, convertible-preferred conversion.
4. Q1-2026 Form 10-Q (filed May 2026) — Q1’26 segment margins, LOGCAP and mining charges, shares/equity (BVPS), NuScale held-for-sale.
5. DEF 14A Proxy Statement, filed 2026-03-12 — executive incentive metrics/weights (AIP, LTI), board changes, CEO/CFO appointments.
6. Form 4 corpus (152 filings, 2021–2026) — insider transactions (no open-market purchases); Form 144 cluster (June 2026).
7. 8-K corpus (2024–2026) — earnings, awards, buyback authorization, management/board changes.

Primary — Earnings-Call Transcripts (ROIC.ai)

8. FLR Q1-2026 earnings call, 2026-05-08 — Q1 miss, charges, FY26 guidance, award pipeline, data-center/power commentary.
9. FLR Q4-2025 earnings call, 2026-02-17 — FY25 results, Santos, FY26 outlook, buyback, 2028 objectives.

Primary — Company Press Releases (BusinessWire / Fluor IR)

10. “Fluor Reports First Quarter 2026 Results,” 2026-05-08. https://www.businesswire.com/news/home/20260508381076/en/
11. “Fluor Divests Equity Stake in Mexico JV” (ICA-Fluor, $175M), 2026-07-16. https://www.businesswire.com/news/home/20260716418693/en/
12. “Fluor Enters into Long-Term Agreement with Aramco,” 2026-07-07. https://www.businesswire.com/news/home/20260706972759/en/
13. “Fluor JV Receives Limited Notice to Proceed for LNG Canada Phase 2 Expansion,” 2026-06-01. https://www.businesswire.com/news/home/20260601873664/en/
14. “Fluor Awarded FEED for Petrochemical Facility in Bahrain,” 2026-07-21. https://www.businesswire.com/news/home/20260721846524/en/
15. “Fluor Awarded Feasibility Study Services for Anglo American’s Woodsmith Mining Project,” 2026-05-07. https://www.businesswire.com/news/home/20260507991035/en/
16. “Fluor JV Reaches Substantial Completion on CTA Red and Purple Line Project,” 2026-07-01. https://www.businesswire.com/news/home/20260701677767/en/

Quantitative Cross-Checks (third-party aggregated; reconciled to filings)

17. ROIC.ai — income statement, balance sheet, cash flow, enterprise value, peer EV/EBITDA & EV/Sales (PWR, MTZ, J, EME, ACM, KBR), profitability ratios. Note: ROIC’s computed ratios were unreliable for FLR (charge/NuScale distortion) — used line items only.
18. AZI (azitrading.com) — valuation_index own-history percentiles (P/E 56.4th, P/B 87.6th, P/S 99.7th, composite 81.2th); daily price/OHLCV CSV (5-year adjusted series; 5yr low $14.60 / high $58.93). BVPS field ($16.32) did not reconcile to the filing ($21.34) — filing used.
19. FactorsToday (factorstoday.com/api) — factor loadings (Market +1.15, Momentum +0.48, DividendYield +0.43, SmallSize +0.31, Liquidity −0.60; beta 1.51), leaderboard (lifetime +1.75%/yr, max DD −95.9%, y5 +28%/yr, m3 +56% annualized), related-stock comp cross-check.

Secondary — Trade/Financial Press (triage; confirmed against primary)

20. “Fluor Has Finished Selling Its NuScale Power Stock…” — Motley Fool, 2026-05-02 (NuScale exit complete, ~$2.4B).
21. “Fluor: Too Many Headwinds Are Emerging (Rating Downgrade)” — Seeking Alpha, 2026-05-13.
22. “Fluor Q1 Earnings & Revenues Miss Estimates, Stock Down” — Zacks, 2026-05-11 (−15.2% on 8-May).
23. “Fluor Q1 Earnings Call Highlights” — MarketBeat, 2026-05-10 (legal charge + mining cost increase).
24. “Fluor Corporation (NYSE:FLR) Receives Consensus Recommendation of ‘Moderate Buy’” — DefenseWorld/MarketBeat, 2026-04-15.
25. GuruFocus GF Value notes (FLR $43.60–43.73 GF Value vs ~$49–50 price), June 2026.
26. Peer-comparison articles (EMCOR vs Fluor, MasTec vs Fluor, United Rentals vs Fluor) — Fool/Zacks, June–July 2026 (context only).